https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19220 Wed 11 Apr 2018 17:23:23 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19222 Wed 11 Apr 2018 16:57:54 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18250 1:80) and frequency of self-reported flares (SRF) in participants with clinical autoimmunity (SLE). 25(OH)D levels of 121 females were quantified and compared. The cohort consisted of 80 ACR defined SLE patients and 41 age and sex matched controls. Association analysis of log2 (25(OH)D) levels and ANA 80 positivity was undertaken via two-sample t-tests and regression models. Significant differences were found for 25(OH)D levels (mean: control 74nmol/L (29.5ng/ml); SLE 58nmol/L (23.1ng/ml), P = 0.04), 25(OH)D deficiency (P = 0.02). Regression models indicate that, for a twofold rise in 25(OH)D level, the odds ratio (OR) for ANA-positivity drops to 36% of the baseline OR. No link was found between SRF-days and 25(OH)D levels. Our results support links between vitamin D deficiency and expression of serological autoimmunity and clinical autoimmunity (SLE). However, no demonstrable association between 25(OH)D and SRF was confirmed, suggesting independent influences of other flare-inducing factors. Results indicate that SLE patients have high risk of 25(OH)D deficiency and therefore supplementation with regular monitoring should be considered as part of patient management.]]> Wed 11 Apr 2018 16:45:13 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16954 Wed 11 Apr 2018 16:16:16 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14765 Wed 11 Apr 2018 11:44:11 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:28475 Wed 11 Apr 2018 09:23:05 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18544 Sat 24 Mar 2018 07:50:17 AEDT ]]>